These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22007661)

  • 1. Predicting the in vivo mechanism of action for drug leads using NMR metabolomics.
    Halouska S; Fenton RJ; Barletta RG; Powers R
    ACS Chem Biol; 2012 Jan; 7(1):166-71. PubMed ID: 22007661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824).
    Baptista R; Fazakerley DM; Beckmann M; Baillie L; Mur LAJ
    Sci Rep; 2018 Mar; 8(1):5084. PubMed ID: 29572459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Mycobacterium activity of microbial peptides in a silkworm infection model with Mycobacterium smegmatis.
    Yagi A; Uchida R; Hamamoto H; Sekimizu K; Kimura KI; Tomoda H
    J Antibiot (Tokyo); 2017 May; 70(5):685-690. PubMed ID: 28446822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying and Tackling Emergent Vulnerability in Drug-Resistant Mycobacteria.
    Padiadpu J; Baloni P; Anand K; Munshi M; Thakur C; Mohan A; Singh A; Chandra N
    ACS Infect Dis; 2016 Sep; 2(9):592-607. PubMed ID: 27759382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis.
    Singh S; Roy KK; Khan SR; Kashyap VK; Sharma A; Jaiswal S; Sharma SK; Krishnan MY; Chaturvedi V; Lal J; Sinha S; Dasgupta A; Srivastava R; Saxena AK
    Bioorg Med Chem; 2015 Feb; 23(4):742-52. PubMed ID: 25614114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis.
    Lelovic N; Mitachi K; Yang J; Lemieux MR; Ji Y; Kurosu M
    J Antibiot (Tokyo); 2020 Nov; 73(11):780-789. PubMed ID: 32472054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria.
    Kaur D; Khuller GK
    Int J Antimicrob Agents; 2001 Jan; 17(1):51-5. PubMed ID: 11137649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors.
    Altaf M; Miller CH; Bellows DS; O'Toole R
    Tuberculosis (Edinb); 2010 Nov; 90(6):333-7. PubMed ID: 20933470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain.
    Saxena S; Samala G; Renuka J; Sridevi JP; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2015 Apr; 23(7):1402-12. PubMed ID: 25766629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and structural investigations on phosphoribosylpyrophosphate synthetase from Mycobacterium smegmatis.
    Donini S; Garavaglia S; Ferraris DM; Miggiano R; Mori S; Shibayama K; Rizzi M
    PLoS One; 2017; 12(4):e0175815. PubMed ID: 28419153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrogen deprivation induces triacylglycerol accumulation, drug tolerance and hypervirulence in mycobacteria.
    Santucci P; Johansen MD; Point V; Poncin I; Viljoen A; Cavalier JF; Kremer L; Canaan S
    Sci Rep; 2019 Jun; 9(1):8667. PubMed ID: 31209261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.
    Guillemont J; Meyer C; Poncelet A; Bourdrez X; Andries K
    Future Med Chem; 2011 Sep; 3(11):1345-60. PubMed ID: 21879841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A short-term model for preliminary screening of potential anti-tubercular compounds.
    Jhamb SS; Singh PP
    Scand J Infect Dis; 2009; 41(11-12):886-9. PubMed ID: 19922075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH; Smith PW
    Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting tuberculosis: a glimpse of promising drug targets.
    Arora N; Banerjee AK
    Mini Rev Med Chem; 2012 Mar; 12(3):187-201. PubMed ID: 22356190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
    Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
    Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug susceptibility testing of mature Mycobacterium tuberculosis H37Ra and Mycobacterium smegmatis biofilms with calorimetry and laser spectroscopy.
    Solokhina A; Bonkat G; Kulchavenya E; Braissant O
    Tuberculosis (Edinb); 2018 Dec; 113():91-98. PubMed ID: 30514518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
    Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
    Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of TB-E12 as a novel FtsZ inhibitor with anti-tuberculosis activity.
    Lin Y; Zhang H; Zhu N; Wang X; Han Y; Chen M; Jiang J; Si S
    Tuberculosis (Edinb); 2018 May; 110():79-85. PubMed ID: 29779778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.